Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessMoneycontrol ResearchDivis Lab: GLP-1 opportunity to unfold in the medium term

    Divis Lab: GLP-1 opportunity to unfold in the medium term

    Global sales from these drugs in Q3 CY2024 were a staggering $11.2 billion. Street estimates for GLP 1 drugs sales for anti-diabetic and/or obesity control are upwards of $150 billion in 2030.

    Anubhav Sahu
    December 24, 2024 / 09:25 IST
    Strong custom synthesis growth visibility
    • PRO Panorama

      Moneycontrol Pro Panorama | An advent calendar for markets

      Nov 14, 2025 / 03:20 PM IST

      In November 14 edition of Moneycontrol Pro Panorama: Is the gold rally a warning about inflation ahead, thematic schemes are boomi...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender | Samvat 2082: The Will to Rise

      Oct 18, 2025 / 10:00 AM IST

      After a turbulent Samvat 2081, the markets step into the new year not with fireworks but with quiet resolve and the will to rise

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More